Sevoflurane for Sedation in Acute Respiratory Distress Syndrome. A Randomized Controlled Pilot Study.

Published on Sep 9, 2016in American Journal of Respiratory and Critical Care Medicine17.452
· DOI :10.1164/RCCM.201604-0686OC
Matthieu Jabaudon17
Estimated H-index: 17
,
Pierre Boucher1
Estimated H-index: 1
+ 15 AuthorsJean-Michel Constantin42
Estimated H-index: 42
Sources
Abstract
Rationale: Sevoflurane improves gas exchange, and reduces alveolar edema and inflammation in preclinical studies of lung injury, but its therapeutic effects have never been investigated in acute respiratory distress syndrome (ARDS).Objectives: To assess whether sevoflurane would improve gas exchange and inflammation in ARDS.Methods: We did a parallel, open-label single-center randomized controlled trial at three intensive care units from a French university hospital between April 2014 and February 2016. Adult patients were randomized within 24 hours of moderate-to-severe ARDS onset to receive either intravenous midazolam or inhaled sevoflurane for 48 hours. The primary outcome was the PaO2/FiO2 ratio on Day 2. Secondary endpoints included alveolar and plasma levels of cytokines and soluble form of the receptor for advanced glycation end-products, and safety. Investigators who did the analyses were masked to group allocation. Analysis was by intention to treat.Measurements and Main Results: Twenty-five pat...
📖 Papers frequently viewed together
99 Citations
25 Citations
34 Citations
References51
Newest
#1Angela Jerath (TGH: Toronto General Hospital)H-Index: 14
#2Matteo Parotto (TGH: Toronto General Hospital)H-Index: 15
Last. Niall D. Ferguson (UHN: University Health Network)H-Index: 51
view all 4 authors...
Volatile anesthetic agent use in the intensive care unit, aided by technological advances, has become more accessible to critical care physicians. With increasing concern over adverse patient consequences associated with our current sedation practice, there is growing interest to find non–benzodiazepine-based alternative sedatives. Research has demonstrated that volatile-based sedation may provide superior awakening and extubation times in comparison with current intravenous sedation agents (pro...
32 CitationsSource
#1Christopher Uhlig (TUD: Dresden University of Technology)H-Index: 8
#2Thomas Bluth (TUD: Dresden University of Technology)H-Index: 10
Last. Marcelo Gama de Abreu (TUD: Dresden University of Technology)H-Index: 33
view all 12 authors...
It is not known whether modern volatile anesthetics are associated with less mortality and postoperative pulmonary or other complications in patients undergoing general anesthesia for surgery. A systematic literature review was conducted for randomized controlled trials fulfilling following criteria: (1) population: adult patients undergoing general anesthesia for surgery; (2) intervention: patients receiving sevoflurane, desflurane, or isoflurane; (3) comparison: volatile anesthetics versus tot...
66 CitationsSource
#1Giacomo Bellani (University of Milan)H-Index: 36
#2John G. Laffey (U of T: University of Toronto)H-Index: 56
Last. Antonio Pesenti (University of Milan)H-Index: 69
view all 16 authors...
Importance Limited information exists about the epidemiology, recognition, management, and outcomes of patients with the acute respiratory distress syndrome (ARDS). Objectives To evaluate intensive care unit (ICU) incidence and outcome of ARDS and to assess clinician recognition, ventilation management, and use of adjuncts—for example prone positioning—in routine clinical practice for patients fulfilling the ARDS Berlin Definition. Design, Setting, and Participants The Large Observational Study ...
1,448 CitationsSource
Rationale: Levels of the soluble form of the receptor for advanced glycation end-products (sRAGE) are elevated during acute respiratory distress syndrome (ARDS) and correlate with severity and prognosis. Alveolar fluid clearance (AFC) is necessary for the resolution of lung edema but is impaired in most patients with ARDS. No reliable marker of this process has been investigated to date.Objectives: To verify whether sRAGE could predict AFC during ARDS.Methods: Anesthetized CD-1 mice underwent or...
75 CitationsSource
#1Russell ChabanneH-Index: 9
#2Sébastien PerbetH-Index: 22
Last. Jean-Michel ConstantinH-Index: 42
view all 8 authors...
Abstract Sevoflurane sedation in the intensive care unit is possible with a special heat and moisture exchanger called the Anesthetic Conserving Device (ACD) (AnaConDa; Sedana Medical AB, Uppsala, Sweden). The ACD, however, may corrupt ventilatory mechanics when used during the weaning process of intensive care unit patients. The authors compared the ventilatory effects of light-sedation with sevoflurane administered with the ACD and those of classic management, consisting of a heated humidifier...
19 CitationsSource
#1Louise Walther Sturesson (Lund University)H-Index: 5
#2Mikael Bodelsson (Lund University)H-Index: 18
Last. Gunnar Malmkvist (Lund University)H-Index: 12
view all 4 authors...
The anaesthetic conserving device AnaConDa(®) (ACD) reflects exhaled anaesthetic agents thereby facilitating the use of inhaled anaesthetic agents outside operating theatres. Expired CO2 is, however, also reflected causing a dead space effect in excess of the ACD internal volume. CO2 reflection from the ACD is attenuated by humidity. This study tests the hypothesis that sevoflurane further attenuates reflection of CO2. An analysis of clinical implications of our findings was performed.
18 CitationsSource
Introduction Acute severe asthma is a life-threatening form of bronchial constriction in which the progressively worsening airway obstruction is unresponsive to the usual appropriate bronchodilator therapy. Pathophysiological changes restrict airflow, which leads to premature closure of the airway on expiration, impaired gas exchange, and dynamic hyperinflation (“air-trapping”). Additionally, patients suffering from asthma for a prolonged period of time usually have serious comorbidities. These ...
11 CitationsSource
#1Sébastien PerbetH-Index: 22
#2Bourdeaux DH-Index: 1
Last. Jean-Etienne BazinH-Index: 22
view all 8 authors...
A B S T R A C T Background. Little is known regarding sevoflurane kinetics and toxicity during long-term sedation of intensive care unit (ICU) patients using the AnaConDa ® system. The objective of the present study was to establish a pharmacokinetic description of 48-h sevoflurane administration, and to estimate plasma concentrations of metabolites. Methods. Forty-eight hour sedation with sevoflurane vaporized via an AnaConDa ® device, with an end-tidal concentration objective of 1.5% (v/v), wa...
18 Citations
The anesthetic conserving device (ACD) reduces consumption of volatile anesthetic drug by a conserving medium adsorbing exhaled drug during expiration and releasing it during inspiration. Elevated arterial CO2 tension (PaCO2) has been observed in patients using the ACD, despite tidal volume increase to compensate for larger apparatus dead space. In a test lung using room temperature dry gas, this was shown to be due to adsorption of CO2 in the ACD during expiration and release of CO2 during the ...
12 CitationsSource
#1D. SchutteH-Index: 1
#2A.M. Zwitserloot (Radboud University Nijmegen Medical Centre)H-Index: 1
Last. Joris Lemson (Radboud University Nijmegen Medical Centre)H-Index: 17
view all 6 authors...
Background Asthma is a common disease in children and often develops early in life. This multicentre retrospective case series describe the use and effectiveness of sevoflurane inhalation therapy in a series of children with severe asthma in the paediatric intensive care unit (PICU). Methods Seven children ranging from 4 to 13 yr of age admitted to the PICU of two tertiary care hospitals in the Netherlands were included. They all were admitted with the diag-nosis of severe asthma requiring invas...
22 CitationsSource
Cited By44
Newest
#1Mahmoud A Ammar (Yale University)H-Index: 3
#2Gretchen Sacha (Cleveland Clinic)H-Index: 7
Last. Abdalla A. Ammar (Yale University)H-Index: 1
view all 7 authors...
The rapid spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a global pandemic. The 2019 coronavirus disease (COVID-19) presents with a spectrum of symptoms ranging from mild to critical illness requiring intensive care unit (ICU) admission. Acute respiratory distress syndrome is a major complication in patients with severe COVID-19 disease. Currently, there are no recognized pharmacological therapies for COVID-19. However, a large number of COVID-19 patients r...
3 CitationsSource
#1Azzeddine KermadH-Index: 1
Last. Andreas Meiser (Saarland University)H-Index: 7
view all 5 authors...
Source
#1Hari Prasad Osuru (UVA: University of Virginia)H-Index: 3
#2Umadevi Paila (UVA: University of Virginia)H-Index: 5
Last. Robert H. Thiele (UVA: University of Virginia)H-Index: 22
view all 5 authors...
Background: Volatile anesthetic agents may protect against organ dysfunction in the setting of critical illness and infection. The goal of this study was to study the impact of Sepsis-inflammation on hepatic subcellular energetics in animals anesthetized with both Propofol (intravenous anesthetic agent and GABA agonist) and Isoflurane (volatile anesthetic). Methods: Sprague-Dawley rats were anesthetized with propofol or isoflurane. Rats in each group were randomized to celiotomy and closure (con...
Source
#1Gerald Chanques (University of Montpellier)H-Index: 43
#2Jean-Michel Constantin (University of Paris)H-Index: 19
Last. John P. Kress (U of C: University of Chicago)H-Index: 42
view all 22 authors...
Acute Respiratory Distress Syndrome (ARDS) is one of the most demanding conditions in an Intensive Care Unit (ICU). Management of analgesia and sedation in ARDS is particularly challenging. An expert panel was convened to produce a "state-of-the-art" article to support clinicians in the optimal management of analgesia/sedation in mechanically ventilated adults with ARDS, including those with COVID-19. Current ICU analgesia/sedation guidelines promote analgesia first and minimization of sedation,...
1 CitationsSource
On January 4 2020, the World Health Organization (WHO) reported the emergence of a cluster of pneumonia cases in Wuhan, China due to a new coronavirus, the SARS-CoV-2. A few weeks later, hospitals had to put in place a series of drastic measures to deal with the massive influx of suspected COVID-19 (COronaroVIrus Disease) patients while securing regular patient care, in particular in the intensive care units (ICU). Since March 12th, 77 of the 685 COVID-19 patients admitted to our hospital requir...
Source
Last. Matthieu Jabaudon (VUMC: Vanderbilt University Medical Center)H-Index: 2
view all 13 authors...
Source
#1N. FerrièreH-Index: 1
#2L. BodenesH-Index: 1
Last. Erwan L'HerH-Index: 11
view all 4 authors...
1 CitationsSource
#1Zuodi Liang (PRC: China Medical University (PRC))H-Index: 4
#2Heng Zhou (PRC: China Medical University (PRC))H-Index: 1
Last. Ling Pei (PRC: China Medical University (PRC))H-Index: 3
view all 6 authors...
Source
#1Gertrude J Nieuwenhuijs-Moeke (UG: University of Groningen)H-Index: 8
#2Jayant S. Jainandunsing (UG: University of Groningen)H-Index: 9
Last. Michel Struys (UGent: Ghent University)H-Index: 48
view all 3 authors...
4 CitationsSource
#1Angela Jerath (Sunnybrook Health Sciences Centre)H-Index: 1
#1Angela JerathH-Index: 14
Last. Brian H. Cuthbertson (U of T: University of Toronto)H-Index: 11
view all 3 authors...
Hospitals worldwide are experiencing a shortage in essential intravenous sedative medications. This is attributable to high number and high sedative needs of COVID-19 critical care patients with disruption of drug supply chains. Inhaled volatile anesthetic agents are an abundant resource and readily implementable solution for providing ICU sedation. Inhaled volatile agents may also provide important pulmonary benefits for COVID-19 patients with ARDS that could improve gas exchange and reduce tim...
5 CitationsSource